Michael C. Ruddy, M.D., F.A.C.P

Undergraduate College: Providence College, Providence, RI

Four-year National Institutes of Health full scholarship for Honors Science Program

Medical School: Rutgers-New Jersey Medical School, Newark, NJ

Medical Residency: Rutgers-Robert Wood Johnson Medical School Affiliated Hospitals, Piscataway, NJ
Chief Medical Resident: Rutgers-Robert Wood Johnson Medical School Affiliated Hospitals

Renal Fellowship: New York-Presbyterian Weill Cornell Medical Center, New York, NY

Fellow, American College of Physicians
Board Certified in Internal Medicine and Nephrology by the American Board of Internal Medicine

Current Academic Positions:
· Clinical Associate professor of Medicine and Adjunct Associate Professor of Pharmacology, Rutgers-Robert Wood Johnson Medical School
, Piscataway, NJ

 · Chief Section of Nephrology –University Medical Center of Princeton at Plainsboro, NJ

Honors and Awards:

·      Top Doctor New York Metro Area Castle-Connolly Medical, Ltd., 2001 2013

·      Alpha Omega Alpha - Inducted as a faculty member; Rutgers- Robert Wood Johnson Medical School – 2006

·      Top Doctor New Jersey Monthly - November, 2006

·      Volunteer Faculty Award Rutgers-Robert Wood Johnson Medical School – 2005

·      Research Mentor of the Year- medical housestaff of the RWJ Medical School Residency program - 2004.

·      Co-Teacher of the Year, Medical Housestaff, RWJMS Program -2003.

·      Americas Top Physicians Consumers Research Council of America, 2003-2008

·      Cited among the first 200 physicians in the US to receive designation as a    Specialist in Clinical Hypertension by the American Society of Hypertension, 1999.

·      31st Annual Harold J Jeghers Lecturer, Rutgers-New Jersey Medical School, 1999.

·      President, New Jersey Society of Hypertension, 1992-93

 

                                      SELECTED PUBLICATIONS

Ruddy MC. Water metabolism and disorders of plasma sodium and potassium concentration. In: Manual for Clinical Nephrology. Stenzel KH, Cheigh J, eds.The Hague:Martinus Nijoff Publ., 30-67, 1981.

Ruddy MC, Atlas SA, Salerno F. Hypertension associated with a renin-producing adenocarcinoma of the pancreas.  New England Journal of Medicine.  307:993-997, 1982.

Ruddy MC. Labile Hypertension.  Journal of the American Medical Association. 248:1642, 1982.

Ruddy MC, Rubin AL, Novogrodsky A, Stenzel KH. Decreased macrophage mediated suppression of lymphocyte activation in chronic renal failure.  American Journal of Medicine  75:571-579, 1983.

Masur H, Franciolo P, Ruddy MC, Murray H. Vancomycin serum levels and toxicity in chronic hemodialysis patients with staphylococcus aureus bacteremia.  Clinical Nephrology  20:85-88, 1983.

Kostis J, Ruddy MC. The use of pindolol in the treatment of hypertension. Primary Cardiology  9:53-76, 1983.

Atlas SA, Hesson TE, Sealey JE, Laragh JH, Ruddy MC, Aurell M. Characterization of inactive renin ("prorenin") from renin-secreting tumors of non-renal origin: similarity to inactive renin from kidney and normal plasma. Journal of Clinical Investigation. 73:437-447, 1984.

Ruddy MC, Barone J. Pharmacology of Renal Hypertension. In: Hypertension and the Kidney.  Cheigh J, Stenzel KH, eds.  The Hague:  Martinus Nijoff Publ., 1986.

Ruddy MC. Selection of Initial Therapy in Essential Hypertension. In:  Pharmacological Treatment of Cardiovascular Disease edited by EA DeFelice, JB Kostis. Medical Examination Publishing Company 6:93-100, 1986.

Sherman RA, Ruddy MC. Suppression of Aldosterone Production by low-dose Heparin.  American Journal of Nephrology 6:165-8, 1986.

Ruddy MC, Bialy GB. Angiotensin Converting Enzyme Inhibitors in Combination Therapy. In: Angiotensin Converting Enzyme Inhibitors. ed JB Kostis, E De Felice, Alan R. Liss, Inc. New York, NY, 1987.

Ruddy MC, Amorosa JK. Renovascular Hypertension: The Diagnostic Role of Radiologic Techniques. Applied Imaging. Volume 6 No. 1:1-5, 1988.

Ruddy MC, Bialy GB, Malka ES, Lacy CR, Kostis JB. The Relationship of Plasma Renin Activity to Clinic and Ambulatory Blood Pressure in Elderly People with Isolated Systolic Hypertension.  Journal of  Hypertension 1988, 6 (suppl 4):S412-S415.

Bialy GB, Ruddy MC, Malka ES, Kamalakannan N. Comparison of Office, Home and 24-Hour Ambulatory Blood Pressures in Borderline and Mild Hypertension. Angiology 752-760, 1988.

Ruddy MC, Bialy GB, Kostis JB. Intrinsic Sympathomimetic Activity Counteracts Beta Blocker Inhibition of Renin Activation. Angiology 40:45-50, 1989.

Ruddy MC. et. al. The effects of benazepril, a new angiotensin- converting enzyme inhibitor, in mild to moderate essential hypertension:  A multicenter study. Clinical Pharmacology  and Therapeutics 1991:49(3):322-329.

Ruddy MC, Arora A, Malka E, Bialy GB. Blood Pressure Variability and Urinary Electrolyte Excretion in Normotensive Adults. American Journal of Hypertension 1993:6:480-486.

Carson JL, Ruddy MC, Brolin, RE, Duff A, Cody RP.  The effect of gastric bypass surgery on hypertension in morbidly obese patients. Archives of Internal Medicine 1994.  Vol 154, P 193-200.

Ruddy MC, Kostis JB, Frishman W. Drugs that Inhibit the Renin Angiotensin System. In  Cardiovascular Pharmacotherapeutics.  Frishman W, Sonnenblick E, eds.  McGraw Hill, New York,1997.

Ruddy MC.  The INSIGHT and NORDIL Trials: Are calcium antagonists equivalent to established drug therapies for cardiovascular protection? Current Hypertension Reports 2001; 3:289-296.

Lewis E, Hunsicker L, Clarke W, Berl T, Pohl M, Lewis J, Ritz E, Atkins R, Rhode R and Raz I, for the Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-860.

Ruddy MC.  Angiotensin II Receptor Blockade in Diabetic Nephropathy. Editiorial.Am J Hypertension, 2002; 15:468-471.

Ferrario C, Smith RD, Brosnihan K, Chappell M, Campese V, Vesterqvisy O, Liao W, Ruddy M, Grim C.  Effects of Omapatrilat on the renin angiotensin system in salt sensitive hypertension. Am J Hypertension 2002;15:557-564.

Ruddy MC, Kostis JB. Angiotensin II Receptor Antagonists. In Hypertension: A Companion to Brenner & Rectors The Kidney.  2nd edition, Oparil S, Weber M, eds. W.B. Saunders Company, Philadelphia, 2005.

Ruddy MC. Unmet Needs in Managing Hypertension: Potential Role of Direct Renin Inhibition. Postgraduate Medicine 2010;122:203-212.

  

 

 

Grace B. Bialy, M.D., F.A.C.P

 

High School: Batten High School, Elizabeth, NJ

Undergraduate College: Rutgers University

Medical School: Wroclaw Medical Acadamey, Wroclaw, Poland

Medical Residency: Rutgers-RWJMS Affilaited Hospitals

Nephrology/Hypertension Fellowship: Rutgers-RWJ UH.

Current Academic Position: Rutgers-RWJMS Clinical Associate Professor of Medicine

 

Honors and Awards:

· 2003 – “Co-Teacher of the Year”, medical housestaff, Rutgers-RWJMS

· Listed among “America’s Top Physicians”, Consumers Reasearch Council of America, 2003 - 2008

· Designated as a Specialist in Clinical Hypertension by the American Society of Hypertension

· Fellow of the American College of Physicians

· Board Certified in Nephrology and Internal Medicine by the American Board of Internal Medicine

 

 

 

Vadim A Finkielstein, M.D., F.A.S.N

 

High School: Stuyvesant High School, New York, NY

Undergraduate College: Johns Hopkins University

Medical School: Johns Hopkins University School of Medicine

Residency: North Shore-Long Island Jewish Medical Center

Nephrology Fellowship: New York University Medical Center

Current Academic Position: Rutgers-RWJMS Clinical Associate Professor of Medicine

 

Honors and Awards:

· 2005 - Designated as a Specialist in Clinical Hypertension by the American Society of Hypertension

· Teacher of the Year Award,Rutgers-RWJMS - 2003 -2007,2010,2012,2013

· 2004, 2005 – “Co-Teacher of the Year”, medical housestaff, Rutgers-RWJMS

· 2002, 2003 – Teacher of the Year, medical housestaff, NYU Medical Center

· 2001- “Medical Resident Teacher of the Year”, LI Jewish Medical Center

· Board Certified in Nephrology and Internal Medicine by the American Board of Internal Medicine

· 1989 - Captain and MVP of the US Junior Olympic Men’s Volleyball Team

· 1993- Elected to Phi Beta Kappa

· University Medical Center of Princeton at Plainsboro - Teacher of the Year - 2012

 

                                                        PUBLICATIONS

  Strategies for Preventing Calcium Oxlate Stones, Vadim A. Finkielstein and David S.Goldfarb May 2006;174(10).

 

 

 

 

 

Seema Basi, M.D., M.S.C.I., F.A.S.N.*

 

High School: West Windsor Plainsboro South, Princeton Junction, NJ - National Merit Finalist

Undergraduate College: Northwestern University, Evanston, IL Major in Molecular Biology.  Elected to Phi Beta kappa as a junior.

Medical School: Northwestern University Medical School, Chicago, IL

Medical Residency: Baylor University College of Medicine Medical Center, Houston, TX

Nephrology Fellowship: Vanderbilt University Medical Center, Nashville, TN

Masters of Science in Clinical Investigation: Vanderbilt University, Nashville, TN

Current Academic Position: Rutgers-RWJMS Clinical Assistant Professor

 

Honors and Awards:

· Designated as a Specialist in Clinical Hypertension by the American Society of Hypertension

· Board Certified in Internal Medicine and Nephrology

· 2006 & 2007 Excellence in Teaching Award, St.Peters University Hospital/Drexel University College of Medicine

· Fellow of the American Society of Nephrology

· 2004 - NIH funded Clinical Research Scholar

· 2004 - NKF Postdoctoral Research fellowship Grant

· 2003 - Honorable Mention for Outstanding contribution to clinical research – Amgen Young Investigators Forum

· Elected to Phi Beta Kappa as an undergraduate (junior year)

· 7 year Honors Program for combined BA/MD degree at Northwestern University.

 

                                              PUBLICATIONS

Basi S., Fesler P., Mimran A., Lewis JB. Microalbuminuria in Type 2 Diabetes and Hypertension: a Marker, Treatment Target, or Innocent Bystander? Diabetes Care. 2008 Feb;31 Suppl 2:S149-201.

Basi S., Lewis JB.  Microalbuminuria as a Target to Improve Cardiovascular and Renal Outcomes in Diabetic Patients. Current Diabetes Reports. 2007 Dec;7(6):439-42.

Basi S., Lewis JB. Microalbuminuria as a Target to Improve Cardiovascular and Renal Outcomes. AM J Kidney Dis. 2006 Jun;47(6):927-46.

Basi S., Pupim LB., Simmons EM., Sezer MT., Shyr Y., Freedman S., Chetow GM., Metha RL., Paganini E., Himmelfarb J., Ikizler TA. Insulin Resistance in Critically ill Patients with Acute Renal Failure. Am J Physiol Renal Physiol. 2005 Aug;289(2):F259-64. Epub 2005 Apr 19.

Basi S., Schulman G., Fogo AB Multiple Complications in Multiple Myeloma. Am J Kidney Dis. 2005 Mar;45(3):619-23.